These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 16506783)
41. Stoichiometry for activation of neuronal α7 nicotinic receptors. Andersen N; Corradi J; Sine SM; Bouzat C Proc Natl Acad Sci U S A; 2013 Dec; 110(51):20819-24. PubMed ID: 24297903 [TBL] [Abstract][Full Text] [Related]
42. AE Succinimide, an Analogue of Methyllycaconitine, When Bound Generates a Nonconducting Conformation of the α4β2 Nicotinic Acetylcholine Receptor. Qudah T; Quek GX; Indurthi D; Karim N; Halliday JI; Absalom N; McLeod MD; Chebib M ACS Chem Neurosci; 2020 Feb; 11(3):344-355. PubMed ID: 31898891 [TBL] [Abstract][Full Text] [Related]
43. Use of acetylcholine binding protein in the search for novel alpha7 nicotinic receptor ligands. In silico docking, pharmacological screening, and X-ray analysis. Ulens C; Akdemir A; Jongejan A; van Elk R; Bertrand S; Perrakis A; Leurs R; Smit AB; Sixma TK; Bertrand D; de Esch IJ J Med Chem; 2009 Apr; 52(8):2372-83. PubMed ID: 19331415 [TBL] [Abstract][Full Text] [Related]
44. Molecular dynamics of nicotinic acetylcholine receptor correlating biological functions. Xu Y; Luo X; Shen J; Zhu W; Chen K; Jiang H Curr Protein Pept Sci; 2006 Jun; 7(3):195-200. PubMed ID: 16787259 [TBL] [Abstract][Full Text] [Related]
45. Substituted 2-Aminopyrimidines Selective for α7-Nicotinic Acetylcholine Receptor Activation and Association with Acetylcholine Binding Proteins. Kaczanowska K; Camacho Hernandez GA; Bendiks L; Kohs L; Cornejo-Bravo JM; Harel M; Finn MG; Taylor P J Am Chem Soc; 2017 Mar; 139(10):3676-3684. PubMed ID: 28221788 [TBL] [Abstract][Full Text] [Related]
46. Partial activation of α7 nicotinic acetylcholine receptors: insights from molecular dynamics simulations. Shi C; Yu R; Shao S; Li Y J Mol Model; 2013 Feb; 19(2):871-8. PubMed ID: 23086458 [TBL] [Abstract][Full Text] [Related]
47. Complex between α-bungarotoxin and an α7 nicotinic receptor ligand-binding domain chimaera. Huang S; Li SX; Bren N; Cheng K; Gomoto R; Chen L; Sine SM Biochem J; 2013 Sep; 454(2):303-310. PubMed ID: 23800261 [TBL] [Abstract][Full Text] [Related]
48. Possible drug candidates for Alzheimer's disease deduced from studying their binding interactions with alpha7 nicotinic acetylcholine receptor. Gu RX; Gu H; Xie ZY; Wang JF; Arias HR; Wei DQ; Chou KC Med Chem; 2009 May; 5(3):250-62. PubMed ID: 19442215 [TBL] [Abstract][Full Text] [Related]
49. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies. Peng W; Ding F Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024 [TBL] [Abstract][Full Text] [Related]
50. Tethered agonist analogs as site-specific probes for domains of the human α7 nicotinic acetylcholine receptor that differentially regulate activation and desensitization. Wang J; Horenstein NA; Stokes C; Papke RL Mol Pharmacol; 2010 Dec; 78(6):1012-25. PubMed ID: 20823218 [TBL] [Abstract][Full Text] [Related]
51. Comparative study on the use of docking and Bayesian categorization to predict ligand binding to nicotinic acetylcholine receptors (nAChRs) subtypes. Kombo DC; Bencherif M J Chem Inf Model; 2013 Dec; 53(12):3212-22. PubMed ID: 24328365 [TBL] [Abstract][Full Text] [Related]
52. The coupling interface and pore domain codetermine the single-channel activity of the α7 nicotinic receptor. Yan H; Pan N; Xue F; Zheng Y; Li C; Chang Y; Xu Z; Yang H; Zhang J Neuropharmacology; 2015 Aug; 95():448-58. PubMed ID: 25908400 [TBL] [Abstract][Full Text] [Related]
53. An allosteric modulator of alpha7 nicotinic receptors, N-(5-Chloro-2,4-dimethoxyphenyl)-N'-(5-methyl-3-isoxazolyl)-urea (PNU-120596), causes conformational changes in the extracellular ligand binding domain similar to those caused by acetylcholine. Barron SC; McLaughlin JT; See JA; Richards VL; Rosenberg RL Mol Pharmacol; 2009 Aug; 76(2):253-63. PubMed ID: 19411608 [TBL] [Abstract][Full Text] [Related]
54. Acetylcholine promotes binding of α-conotoxin MII at α3 β2 nicotinic acetylcholine receptors. Sambasivarao SV; Roberts J; Bharadwaj VS; Slingsby JG; Rohleder C; Mallory C; Groome JR; McDougal OM; Maupin CM Chembiochem; 2014 Feb; 15(3):413-24. PubMed ID: 24420650 [TBL] [Abstract][Full Text] [Related]
55. Modeling binding modes of alpha7 nicotinic acetylcholine receptor with ligands: the roles of Gln117 and other residues of the receptor in agonist binding. Huang X; Zheng F; Stokes C; Papke RL; Zhan CG J Med Chem; 2008 Oct; 51(20):6293-302. PubMed ID: 18826295 [TBL] [Abstract][Full Text] [Related]
56. Serotonin antagonizes the human neuronal alpha7 nicotinic acetylcholine receptor and becomes an agonist after L248T alpha7 mutation. Fucile S; Palma E; Eusebi F; Miledi R Neuroscience; 2002; 110(1):169-79. PubMed ID: 11882381 [TBL] [Abstract][Full Text] [Related]
57. Discovery, synthesis, and structure activity of a highly selective alpha7 nicotinic acetylcholine receptor antagonist. Whiteaker P; Christensen S; Yoshikami D; Dowell C; Watkins M; Gulyas J; Rivier J; Olivera BM; McIntosh JM Biochemistry; 2007 Jun; 46(22):6628-38. PubMed ID: 17497892 [TBL] [Abstract][Full Text] [Related]
58. Photo-induced covalent attachment of agonists as a tool to study allosteric mechanisms of nicotinic acetylcholine receptors. Mourot A; Kotzyba-Hibert F; Goeldner M; Bamberg E J Mol Neurosci; 2006; 30(1-2):3-4. PubMed ID: 17192602 [TBL] [Abstract][Full Text] [Related]